Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 100000 | nM | 20430633 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 13273.94 | nM | 19729316 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 2576.32 | nM | 19734910 | |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 2349.63 | nM | 19877653 | |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 2280.34 | nM | 19481942 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 3723.92 | nM | 11473422 | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 1552.39 | nM | 12932129 | |
NPT402 | Cell Line | Hs-578T | Homo sapiens | GI50 | 1981.53 | nM | 19916528 | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 6266.14 | nM | PubChem BioAssay data set | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 1836.54 | nM | 15711537 | |
NPT319 | Cell Line | B16 | Mus musculus | IC50 | = | 5200 | nM | 23398362 |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 34040.82 | nM | 22197393 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 4731.51 | nM | 25871540 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 1995.26 | nM | 20163893 | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 4539.42 | nM | 8864235 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 3296.1 | nM | 20566771 | |
NPT1174 | Cell Line | A375 | Homo sapiens | IC50 | = | 2640 | nM | DrugMatrix in vitro pharmacology data |
NPT367 | Cell Line | MDA-N | Homo sapiens | GI50 | 262.42 | nM | Open TG-GATES in vivo data: Hematology | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 2328.09 | nM | 22877635 | |
NPT737 | Cell Line | HUVEC | Homo sapiens | IC50 | > | 10000 | nM | 24972008 |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 18323.14 | nM | 17125218 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 3647.54 | nM | 23122818 | |
NPT2 | Others | Unspecified | IC50 | = | 9170 | nM | 17869103 | |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 1114.29 | nM | 17567121 | |
NPT308 | Cell Line | CAKI-1 | Homo sapiens | GI50 | 3013.01 | nM | 24087924 | |
NPT456 | Cell Line | OVCAR-4 | Homo sapiens | GI50 | 100000 | nM | 22642560 | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 82794.22 | nM | 12027767 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 2741.57 | nM | 18341287 | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 2944.42 | nM | 17524651 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 1967.89 | nM | 20462233 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 31477.48 | nM | 19928902 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 2051.16 | nM | 19670881 | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 15310.87 | nM | 23046382 | |
NPT370 | Cell Line | NCI-H23 | Homo sapiens | GI50 | 8669.62 | nM | 23398362 | |
NPT406 | Cell Line | RXF 393 | Homo sapiens | GI50 | 2449.06 | nM | 16643040 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 2349.63 | nM | 15217282 | |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.53 | ug/ml | 10924160 |
NPT180 | Cell Line | HCT-8 | Homo sapiens | ED50 | = | 4.63 | ug/ml | 10924160 |
NPT1091 | Cell Line | RPMI-7951 | Homo sapiens | ED50 | = | 0.49 | ug/ml | 10924160 |
NPT91 | Cell Line | KB | Homo sapiens | ED50 | = | 0.55 | ug/ml | 10924160 |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 4149.54 | nM | 19167886 | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 3019.95 | nM | 11929285 | |
NPT577 | Cell Line | RXF 631 | Homo sapiens | GI50 | 5395.11 | nM | 20439614 | |
NPT399 | Cell Line | SF-295 | Homo sapiens | GI50 | 1663.41 | nM | 19114678 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 3019.95 | nM | 23063566 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 1555.97 | nM | DrugMatrix in vitro pharmacology data | |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 1845.02 | nM | 22686608 | |
NPT394 | Cell Line | EKVX | Homo sapiens | GI50 | 36057.86 | nM | 25647077 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 2483.13 | nM | 19015349 | |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | 2264.64 | nM | 10560729 | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 5407.54 | nM | 10560729 | |
NPT75 | Cell Line | U251 | Homo sapiens | IC50 | = | 9400 | nM | 18579374 |
NPT376 | Cell Line | A498 | Homo sapiens | GI50 | 8452.79 | nM | 20163893 | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 734.51 | nM | 15711537 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 4111.5 | nM | 18077363 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 1241.65 | nM | 12105963 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 3318.94 | nM | 17988094 | |
NPT403 | Cell Line | UACC-257 | Homo sapiens | GI50 | 11324 | nM | PubChem BioAssay data set | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 4207.27 | nM | 19845338 | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 4487.45 | nM | 16989518 | |
NPT83 | Cell Line | MCF7 | Homo sapiens | GI50 | 778.04 | nM | 20702092 | |
NPT457 | Cell Line | BT-549 | Homo sapiens | GI50 | 100000 | nM | 19555121 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 1279.38 | nM | 19388705 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 1811.34 | nM | PubChem BioAssay data set | |
NPT90 | Cell Line | DU-145 | Homo sapiens | GI50 | 2864.18 | nM | 18417256 | |
NPT396 | Cell Line | T47D | Homo sapiens | GI50 | 6698.85 | nM | 20044260 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 5508.08 | nM | 20138517 | |
NPT65 | Cell Line | HepG2 | Homo sapiens | IC50 | = | 2040 | nM | 18710917 |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 19230.92 | nM | 19738026 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 2192.8 | nM | Open TG-GATES in vivo data: Hematology | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 2269.86 | nM | Open TG-GATES in vivo data: Hematology | |
NPT306 | Cell Line | PC-3 | Homo sapiens | GI50 | 4159.11 | nM | Open TG-GATES in vivo data: Hematology | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 9727.47 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 3953.67 | nM | Open TG-GATES in vivo data: Organ Weight | |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 43151.91 | nM | 25735399 | |
NPT82 | Cell Line | MDA-MB-231 | Homo sapiens | GI50 | 100000 | nM | 18163588 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 1267.65 | nM | 16643041 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC216314 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
1.0 | High Similarity | NPC120924 |
1.0 | High Similarity | NPC195919 |
0.9856 | High Similarity | NPC182842 |
0.9712 | High Similarity | NPC185607 |
0.9653 | High Similarity | NPC262623 |
0.9648 | High Similarity | NPC205522 |
0.964 | High Similarity | NPC58229 |
0.9583 | High Similarity | NPC156953 |
0.9583 | High Similarity | NPC239363 |
0.958 | High Similarity | NPC63256 |
0.958 | High Similarity | NPC10304 |
0.9577 | High Similarity | NPC40818 |
0.9577 | High Similarity | NPC106461 |
0.9577 | High Similarity | NPC110639 |
0.9577 | High Similarity | NPC215932 |
0.9577 | High Similarity | NPC14958 |
0.9521 | High Similarity | NPC186507 |
0.9521 | High Similarity | NPC478213 |
0.9521 | High Similarity | NPC124714 |
0.9514 | High Similarity | NPC238366 |
0.951 | High Similarity | NPC85233 |
0.9507 | High Similarity | NPC471590 |
0.9507 | High Similarity | NPC136278 |
0.9504 | High Similarity | NPC476054 |
0.9452 | High Similarity | NPC216769 |
0.9452 | High Similarity | NPC209487 |
0.9452 | High Similarity | NPC269451 |
0.9452 | High Similarity | NPC35763 |
0.9452 | High Similarity | NPC291802 |
0.9452 | High Similarity | NPC181209 |
0.9452 | High Similarity | NPC121522 |
0.9452 | High Similarity | NPC131266 |
0.9452 | High Similarity | NPC245382 |
0.9452 | High Similarity | NPC100263 |
0.9452 | High Similarity | NPC100971 |
0.9452 | High Similarity | NPC153008 |
0.9452 | High Similarity | NPC148497 |
0.9441 | High Similarity | NPC302408 |
0.9441 | High Similarity | NPC231013 |
0.9441 | High Similarity | NPC283002 |
0.9437 | High Similarity | NPC23955 |
0.9437 | High Similarity | NPC113089 |
0.9424 | High Similarity | NPC44573 |
0.9388 | High Similarity | NPC250557 |
0.9388 | High Similarity | NPC57211 |
0.9388 | High Similarity | NPC472408 |
0.9388 | High Similarity | NPC280937 |
0.9388 | High Similarity | NPC128961 |
0.9384 | High Similarity | NPC45291 |
0.9384 | High Similarity | NPC279061 |
0.9384 | High Similarity | NPC19980 |
0.9379 | High Similarity | NPC69752 |
0.9375 | High Similarity | NPC93034 |
0.9375 | High Similarity | NPC119660 |
0.9375 | High Similarity | NPC474999 |
0.9371 | High Similarity | NPC165512 |
0.9366 | High Similarity | NPC9966 |
0.9366 | High Similarity | NPC70853 |
0.9329 | High Similarity | NPC19097 |
0.9324 | High Similarity | NPC478238 |
0.9324 | High Similarity | NPC39184 |
0.9324 | High Similarity | NPC130589 |
0.9324 | High Similarity | NPC134287 |
0.932 | High Similarity | NPC52623 |
0.932 | High Similarity | NPC166201 |
0.9315 | High Similarity | NPC10467 |
0.9315 | High Similarity | NPC259058 |
0.9315 | High Similarity | NPC201547 |
0.931 | High Similarity | NPC476058 |
0.9306 | High Similarity | NPC12377 |
0.9301 | High Similarity | NPC293201 |
0.9296 | High Similarity | NPC124467 |
0.9296 | High Similarity | NPC214919 |
0.9296 | High Similarity | NPC29536 |
0.9262 | High Similarity | NPC180340 |
0.9257 | High Similarity | NPC472915 |
0.9252 | High Similarity | NPC226973 |
0.9252 | High Similarity | NPC208043 |
0.9252 | High Similarity | NPC308451 |
0.9247 | High Similarity | NPC139293 |
0.9247 | High Similarity | NPC264289 |
0.9247 | High Similarity | NPC181250 |
0.9247 | High Similarity | NPC92722 |
0.9247 | High Similarity | NPC200060 |
0.9247 | High Similarity | NPC142876 |
0.9247 | High Similarity | NPC333691 |
0.9247 | High Similarity | NPC40290 |
0.9247 | High Similarity | NPC102003 |
0.9247 | High Similarity | NPC264550 |
0.9247 | High Similarity | NPC69430 |
0.9247 | High Similarity | NPC195763 |
0.9241 | High Similarity | NPC299923 |
0.9241 | High Similarity | NPC470511 |
0.9209 | High Similarity | NPC143649 |
0.92 | High Similarity | NPC181960 |
0.92 | High Similarity | NPC476981 |
0.92 | High Similarity | NPC78103 |
0.9195 | High Similarity | NPC213622 |
0.9195 | High Similarity | NPC37392 |
0.9195 | High Similarity | NPC20830 |
0.9195 | High Similarity | NPC472909 |
0.9195 | High Similarity | NPC256612 |
0.9189 | High Similarity | NPC40033 |
0.9189 | High Similarity | NPC134677 |
0.9184 | High Similarity | NPC189270 |
0.9184 | High Similarity | NPC306821 |
0.9184 | High Similarity | NPC5840 |
0.9178 | High Similarity | NPC194653 |
0.9178 | High Similarity | NPC15329 |
0.9178 | High Similarity | NPC139364 |
0.9178 | High Similarity | NPC80710 |
0.9178 | High Similarity | NPC203747 |
0.9178 | High Similarity | NPC254702 |
0.9178 | High Similarity | NPC131451 |
0.9178 | High Similarity | NPC287395 |
0.9178 | High Similarity | NPC183655 |
0.9178 | High Similarity | NPC218490 |
0.9178 | High Similarity | NPC476342 |
0.9172 | High Similarity | NPC310259 |
0.9145 | High Similarity | NPC165549 |
0.9139 | High Similarity | NPC215375 |
0.9139 | High Similarity | NPC62518 |
0.9137 | High Similarity | NPC223354 |
0.9133 | High Similarity | NPC472916 |
0.9133 | High Similarity | NPC303255 |
0.9128 | High Similarity | NPC231018 |
0.9128 | High Similarity | NPC47781 |
0.9128 | High Similarity | NPC86485 |
0.9128 | High Similarity | NPC69394 |
0.9128 | High Similarity | NPC160951 |
0.9128 | High Similarity | NPC176775 |
0.9128 | High Similarity | NPC183878 |
0.9128 | High Similarity | NPC145379 |
0.9128 | High Similarity | NPC22519 |
0.9128 | High Similarity | NPC255350 |
0.9128 | High Similarity | NPC274327 |
0.9122 | High Similarity | NPC149614 |
0.9122 | High Similarity | NPC117579 |
0.9122 | High Similarity | NPC474663 |
0.9122 | High Similarity | NPC256406 |
0.9122 | High Similarity | NPC198615 |
0.9116 | High Similarity | NPC328119 |
0.911 | High Similarity | NPC125449 |
0.911 | High Similarity | NPC188074 |
0.9097 | High Similarity | NPC119663 |
0.9079 | High Similarity | NPC476980 |
0.9079 | High Similarity | NPC298093 |
0.9078 | High Similarity | NPC157944 |
0.9078 | High Similarity | NPC474274 |
0.9073 | High Similarity | NPC474208 |
0.9073 | High Similarity | NPC472911 |
0.9073 | High Similarity | NPC162869 |
0.9073 | High Similarity | NPC48208 |
0.9073 | High Similarity | NPC167595 |
0.9073 | High Similarity | NPC210084 |
0.9073 | High Similarity | NPC475267 |
0.9073 | High Similarity | NPC472914 |
0.9073 | High Similarity | NPC258644 |
0.9073 | High Similarity | NPC99597 |
0.9073 | High Similarity | NPC245758 |
0.9073 | High Similarity | NPC222814 |
0.9073 | High Similarity | NPC474836 |
0.9073 | High Similarity | NPC96167 |
0.9073 | High Similarity | NPC472913 |
0.9073 | High Similarity | NPC472910 |
0.9073 | High Similarity | NPC156057 |
0.9073 | High Similarity | NPC470402 |
0.9067 | High Similarity | NPC241774 |
0.9067 | High Similarity | NPC34725 |
0.9067 | High Similarity | NPC138360 |
0.9067 | High Similarity | NPC280339 |
0.9067 | High Similarity | NPC50715 |
0.9067 | High Similarity | NPC183597 |
0.9067 | High Similarity | NPC196439 |
0.9067 | High Similarity | NPC189960 |
0.9067 | High Similarity | NPC2928 |
0.9067 | High Similarity | NPC208197 |
0.9067 | High Similarity | NPC163780 |
0.9067 | High Similarity | NPC4455 |
0.9067 | High Similarity | NPC276059 |
0.9067 | High Similarity | NPC227325 |
0.9067 | High Similarity | NPC167815 |
0.9067 | High Similarity | NPC92659 |
0.9067 | High Similarity | NPC122623 |
0.9067 | High Similarity | NPC31018 |
0.9067 | High Similarity | NPC255807 |
0.9067 | High Similarity | NPC201136 |
0.9067 | High Similarity | NPC146165 |
0.9067 | High Similarity | NPC2476 |
0.9067 | High Similarity | NPC32557 |
0.9067 | High Similarity | NPC128863 |
0.9065 | High Similarity | NPC182428 |
0.906 | High Similarity | NPC156222 |
0.906 | High Similarity | NPC222830 |
0.906 | High Similarity | NPC301323 |
0.906 | High Similarity | NPC68882 |
0.906 | High Similarity | NPC292460 |
0.906 | High Similarity | NPC83508 |
0.906 | High Similarity | NPC162313 |
0.906 | High Similarity | NPC293183 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC216314 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9128 | High Similarity | NPD2801 | Approved |
0.9079 | High Similarity | NPD5494 | Approved |
0.8816 | High Similarity | NPD3817 | Phase 2 |
0.8811 | High Similarity | NPD2796 | Approved |
0.8808 | High Similarity | NPD1934 | Approved |
0.8654 | High Similarity | NPD1247 | Approved |
0.8636 | High Similarity | NPD3882 | Suspended |
0.8627 | High Similarity | NPD2393 | Clinical (unspecified phase) |
0.8611 | High Similarity | NPD1510 | Phase 2 |
0.8523 | High Similarity | NPD1511 | Approved |
0.85 | High Similarity | NPD3818 | Discontinued |
0.8477 | Intermediate Similarity | NPD6980 | Clinical (unspecified phase) |
0.8431 | Intermediate Similarity | NPD4380 | Phase 2 |
0.8411 | Intermediate Similarity | NPD1512 | Approved |
0.8375 | Intermediate Similarity | NPD6166 | Phase 2 |
0.8375 | Intermediate Similarity | NPD6168 | Clinical (unspecified phase) |
0.8375 | Intermediate Similarity | NPD6167 | Clinical (unspecified phase) |
0.8365 | Intermediate Similarity | NPD6232 | Discontinued |
0.8344 | Intermediate Similarity | NPD4378 | Clinical (unspecified phase) |
0.8333 | Intermediate Similarity | NPD1240 | Approved |
0.8323 | Intermediate Similarity | NPD7473 | Discontinued |
0.8313 | Intermediate Similarity | NPD3926 | Phase 2 |
0.8291 | Intermediate Similarity | NPD919 | Approved |
0.8278 | Intermediate Similarity | NPD6799 | Approved |
0.8242 | Intermediate Similarity | NPD4338 | Clinical (unspecified phase) |
0.8221 | Intermediate Similarity | NPD7054 | Approved |
0.8219 | Intermediate Similarity | NPD1607 | Approved |
0.8217 | Intermediate Similarity | NPD5402 | Approved |
0.8188 | Intermediate Similarity | NPD1549 | Phase 2 |
0.8171 | Intermediate Similarity | NPD7074 | Phase 3 |
0.8171 | Intermediate Similarity | NPD7472 | Approved |
0.8165 | Intermediate Similarity | NPD4868 | Clinical (unspecified phase) |
0.8153 | Intermediate Similarity | NPD7096 | Clinical (unspecified phase) |
0.8153 | Intermediate Similarity | NPD7819 | Suspended |
0.8121 | Intermediate Similarity | NPD1550 | Clinical (unspecified phase) |
0.8121 | Intermediate Similarity | NPD1552 | Clinical (unspecified phase) |
0.8113 | Intermediate Similarity | NPD4381 | Clinical (unspecified phase) |
0.811 | Intermediate Similarity | NPD5844 | Phase 1 |
0.8089 | Intermediate Similarity | NPD6801 | Discontinued |
0.8082 | Intermediate Similarity | NPD943 | Approved |
0.8077 | Intermediate Similarity | NPD6599 | Discontinued |
0.8054 | Intermediate Similarity | NPD2935 | Discontinued |
0.8024 | Intermediate Similarity | NPD7808 | Phase 3 |
0.8012 | Intermediate Similarity | NPD6797 | Phase 2 |
0.8 | Intermediate Similarity | NPD920 | Approved |
0.8 | Intermediate Similarity | NPD7075 | Discontinued |
0.7987 | Intermediate Similarity | NPD7410 | Clinical (unspecified phase) |
0.7964 | Intermediate Similarity | NPD7251 | Discontinued |
0.7911 | Intermediate Similarity | NPD7411 | Suspended |
0.7871 | Intermediate Similarity | NPD642 | Clinical (unspecified phase) |
0.7867 | Intermediate Similarity | NPD3748 | Approved |
0.7866 | Intermediate Similarity | NPD5242 | Approved |
0.7829 | Intermediate Similarity | NPD970 | Clinical (unspecified phase) |
0.7785 | Intermediate Similarity | NPD1933 | Approved |
0.7778 | Intermediate Similarity | NPD1243 | Approved |
0.7771 | Intermediate Similarity | NPD5403 | Approved |
0.7764 | Intermediate Similarity | NPD8443 | Clinical (unspecified phase) |
0.7756 | Intermediate Similarity | NPD5401 | Approved |
0.7742 | Intermediate Similarity | NPD643 | Clinical (unspecified phase) |
0.7727 | Intermediate Similarity | NPD1878 | Clinical (unspecified phase) |
0.7714 | Intermediate Similarity | NPD5536 | Phase 2 |
0.7702 | Intermediate Similarity | NPD1465 | Phase 2 |
0.7692 | Intermediate Similarity | NPD7993 | Clinical (unspecified phase) |
0.7688 | Intermediate Similarity | NPD6386 | Approved |
0.7688 | Intermediate Similarity | NPD6385 | Approved |
0.7679 | Intermediate Similarity | NPD7804 | Clinical (unspecified phase) |
0.7671 | Intermediate Similarity | NPD2798 | Approved |
0.7667 | Intermediate Similarity | NPD230 | Phase 1 |
0.7667 | Intermediate Similarity | NPD447 | Suspended |
0.7654 | Intermediate Similarity | NPD5353 | Approved |
0.7643 | Intermediate Similarity | NPD2534 | Approved |
0.7643 | Intermediate Similarity | NPD2533 | Approved |
0.7643 | Intermediate Similarity | NPD2532 | Approved |
0.7636 | Intermediate Similarity | NPD6959 | Discontinued |
0.7635 | Intermediate Similarity | NPD3027 | Phase 3 |
0.7613 | Intermediate Similarity | NPD3750 | Approved |
0.7584 | Intermediate Similarity | NPD6859 | Clinical (unspecified phase) |
0.758 | Intermediate Similarity | NPD6143 | Clinical (unspecified phase) |
0.7569 | Intermediate Similarity | NPD1547 | Clinical (unspecified phase) |
0.7568 | Intermediate Similarity | NPD6832 | Phase 2 |
0.755 | Intermediate Similarity | NPD1899 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD7421 | Clinical (unspecified phase) |
0.7548 | Intermediate Similarity | NPD2654 | Approved |
0.7544 | Intermediate Similarity | NPD6559 | Discontinued |
0.7543 | Intermediate Similarity | NPD8397 | Clinical (unspecified phase) |
0.7531 | Intermediate Similarity | NPD37 | Approved |
0.7517 | Intermediate Similarity | NPD3972 | Approved |
0.7516 | Intermediate Similarity | NPD1509 | Clinical (unspecified phase) |
0.7516 | Intermediate Similarity | NPD651 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD9494 | Approved |
0.75 | Intermediate Similarity | NPD7852 | Clinical (unspecified phase) |
0.75 | Intermediate Similarity | NPD7768 | Phase 2 |
0.75 | Intermediate Similarity | NPD3018 | Phase 2 |
0.7468 | Intermediate Similarity | NPD1551 | Phase 2 |
0.7467 | Intermediate Similarity | NPD2313 | Discontinued |
0.7455 | Intermediate Similarity | NPD3749 | Approved |
0.7436 | Intermediate Similarity | NPD2800 | Approved |
0.7425 | Intermediate Similarity | NPD7199 | Phase 2 |
0.7403 | Intermediate Similarity | NPD2799 | Discontinued |
0.7397 | Intermediate Similarity | NPD2981 | Phase 2 |
0.7394 | Intermediate Similarity | NPD4966 | Approved |
0.7394 | Intermediate Similarity | NPD4965 | Approved |
0.7394 | Intermediate Similarity | NPD4967 | Phase 2 |
0.7389 | Intermediate Similarity | NPD4628 | Phase 3 |
0.7386 | Intermediate Similarity | NPD6651 | Approved |
0.7368 | Intermediate Similarity | NPD1612 | Clinical (unspecified phase) |
0.7368 | Intermediate Similarity | NPD1613 | Approved |
0.7363 | Intermediate Similarity | NPD7501 | Clinical (unspecified phase) |
0.736 | Intermediate Similarity | NPD7879 | Clinical (unspecified phase) |
0.7347 | Intermediate Similarity | NPD4379 | Clinical (unspecified phase) |
0.7347 | Intermediate Similarity | NPD2983 | Phase 2 |
0.7347 | Intermediate Similarity | NPD2982 | Phase 2 |
0.7346 | Intermediate Similarity | NPD3226 | Approved |
0.7342 | Intermediate Similarity | NPD6190 | Approved |
0.7337 | Intermediate Similarity | NPD7184 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD1529 | Clinical (unspecified phase) |
0.7317 | Intermediate Similarity | NPD6844 | Discontinued |
0.731 | Intermediate Similarity | NPD3751 | Discontinued |
0.7308 | Intermediate Similarity | NPD2346 | Discontinued |
0.7308 | Intermediate Similarity | NPD2344 | Approved |
0.7305 | Intermediate Similarity | NPD5283 | Phase 1 |
0.7305 | Intermediate Similarity | NPD6234 | Discontinued |
0.7294 | Intermediate Similarity | NPD2403 | Approved |
0.7284 | Intermediate Similarity | NPD1653 | Approved |
0.7283 | Intermediate Similarity | NPD5953 | Discontinued |
0.7278 | Intermediate Similarity | NPD3787 | Discontinued |
0.7273 | Intermediate Similarity | NPD8055 | Clinical (unspecified phase) |
0.7267 | Intermediate Similarity | NPD7286 | Phase 2 |
0.7267 | Intermediate Similarity | NPD1530 | Clinical (unspecified phase) |
0.725 | Intermediate Similarity | NPD7390 | Discontinued |
0.725 | Intermediate Similarity | NPD4357 | Discontinued |
0.7229 | Intermediate Similarity | NPD5978 | Approved |
0.7229 | Intermediate Similarity | NPD5977 | Approved |
0.72 | Intermediate Similarity | NPD4419 | Clinical (unspecified phase) |
0.7193 | Intermediate Similarity | NPD7784 | Clinical (unspecified phase) |
0.7186 | Intermediate Similarity | NPD5019 | Clinical (unspecified phase) |
0.7181 | Intermediate Similarity | NPD1876 | Approved |
0.7143 | Intermediate Similarity | NPD7685 | Pre-registration |
0.7143 | Intermediate Similarity | NPD4307 | Phase 2 |
0.7134 | Intermediate Similarity | NPD7458 | Discontinued |
0.7134 | Intermediate Similarity | NPD6099 | Approved |
0.7134 | Intermediate Similarity | NPD6100 | Approved |
0.7133 | Intermediate Similarity | NPD3266 | Approved |
0.7133 | Intermediate Similarity | NPD3267 | Approved |
0.7125 | Intermediate Similarity | NPD2309 | Approved |
0.7123 | Intermediate Similarity | NPD9268 | Approved |
0.7097 | Intermediate Similarity | NPD5006 | Approved |
0.7097 | Intermediate Similarity | NPD5005 | Approved |
0.7089 | Intermediate Similarity | NPD1471 | Phase 3 |
0.7086 | Intermediate Similarity | NPD1019 | Discontinued |
0.7081 | Intermediate Similarity | NPD6780 | Approved |
0.7081 | Intermediate Similarity | NPD6776 | Approved |
0.7081 | Intermediate Similarity | NPD6781 | Approved |
0.7081 | Intermediate Similarity | NPD6778 | Approved |
0.7081 | Intermediate Similarity | NPD6777 | Approved |
0.7081 | Intermediate Similarity | NPD6782 | Approved |
0.7081 | Intermediate Similarity | NPD6779 | Approved |
0.7076 | Intermediate Similarity | NPD5711 | Approved |
0.7076 | Intermediate Similarity | NPD5710 | Approved |
0.7075 | Intermediate Similarity | NPD17 | Approved |
0.707 | Intermediate Similarity | NPD7033 | Discontinued |
0.7063 | Intermediate Similarity | NPD1241 | Discontinued |
0.7055 | Intermediate Similarity | NPD1940 | Clinical (unspecified phase) |
0.7047 | Intermediate Similarity | NPD9269 | Phase 2 |
0.7039 | Intermediate Similarity | NPD8434 | Phase 2 |
0.7025 | Intermediate Similarity | NPD3539 | Phase 1 |
0.702 | Intermediate Similarity | NPD1470 | Approved |
0.702 | Intermediate Similarity | NPD1203 | Approved |
0.7019 | Intermediate Similarity | NPD5307 | Clinical (unspecified phase) |
0.7019 | Intermediate Similarity | NPD3887 | Approved |
0.7013 | Intermediate Similarity | NPD3268 | Approved |
0.7013 | Intermediate Similarity | NPD1296 | Phase 2 |
0.7011 | Intermediate Similarity | NPD7228 | Approved |
0.7007 | Intermediate Similarity | NPD1651 | Approved |
0.7006 | Intermediate Similarity | NPD6280 | Approved |
0.7006 | Intermediate Similarity | NPD6279 | Approved |
0.7006 | Intermediate Similarity | NPD7549 | Discontinued |
0.6994 | Remote Similarity | NPD7422 | Clinical (unspecified phase) |
0.6993 | Remote Similarity | NPD4908 | Phase 1 |
0.6981 | Remote Similarity | NPD3540 | Phase 1 |
0.6977 | Remote Similarity | NPD7229 | Phase 3 |
0.6973 | Remote Similarity | NPD4420 | Approved |
0.6968 | Remote Similarity | NPD7696 | Phase 3 |
0.6968 | Remote Similarity | NPD7697 | Approved |
0.6968 | Remote Similarity | NPD6233 | Phase 2 |
0.6968 | Remote Similarity | NPD7698 | Approved |
0.6968 | Remote Similarity | NPD7435 | Discontinued |
0.6962 | Remote Similarity | NPD4308 | Phase 3 |
0.6957 | Remote Similarity | NPD6398 | Clinical (unspecified phase) |
0.6946 | Remote Similarity | NPD5890 | Approved |
0.6946 | Remote Similarity | NPD6873 | Phase 2 |
0.6946 | Remote Similarity | NPD5889 | Approved |
0.6944 | Remote Similarity | NPD8150 | Discontinued |
0.6939 | Remote Similarity | NPD1548 | Phase 1 |
0.6933 | Remote Similarity | NPD9717 | Approved |
0.6933 | Remote Similarity | NPD1608 | Approved |
0.6931 | Remote Similarity | NPD7871 | Phase 2 |
0.6931 | Remote Similarity | NPD7870 | Phase 2 |
0.6923 | Remote Similarity | NPD4288 | Approved |
0.6919 | Remote Similarity | NPD8090 | Clinical (unspecified phase) |
PubChem CID   | 165203 |
ChEMBL   | CHEMBL478578 |
ZINC   |
Molecular Weight:   | 342.11 |
ALogP:   | -0.8739 |
MLogP:   | 2.89 |
XLogP:   | 2.625 |
# Rotatable Bonds:   | 9 |
Polar Surface Area:   | 63.22 |
# H-Bond Aceptor:   | 1 |
# H-Bond Donor:   | 0 |
# Rings:   | 3 |
# Heavy Atoms:   | 25 |